These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
407 related items for PubMed ID: 33506730
21. The Association Between Persistence and Adherence to Disease-Modifying Therapies and Healthcare Resource Utilization and Costs in Patients With Multiple Sclerosis. Pardo G, Pineda ED, Ng CD, Sheinson D, Bonine NG. J Health Econ Outcomes Res; 2022; 9(1):111-116. PubMed ID: 35586512 [Abstract] [Full Text] [Related]
22. Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort study. Chinthammit C, Axon DR, Mollon L, Taylor AM, Pickering M, Black H, Warholak T, Campbell PJ. J Manag Care Spec Pharm; 2021 Jan; 27(1):64-72. PubMed ID: 33377445 [Abstract] [Full Text] [Related]
23. Medication Adherence, Health Care Utilization, and Costs Among Patients Initiating Oral Oncolytics for Multiple Myeloma or Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Dashputre AA, Gatwood KS, Gatwood J. J Manag Care Spec Pharm; 2020 Feb; 26(2):186-196. PubMed ID: 32011965 [Abstract] [Full Text] [Related]
24. Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population. Wallace AE, Kaila S, Bayer V, Shaikh A, Shinde MU, Willey VJ, Napier MB, Singer JR. J Manag Care Spec Pharm; 2019 Feb; 25(2):205-217. PubMed ID: 30698096 [Abstract] [Full Text] [Related]
25. Predictors of Nonadherence to Topical Intraocular Pressure Reduction Medications Among Medicare Members: A Claims-Based Retrospective Cohort Study. Sheer R, Bunniran S, Uribe C, Fiscella RG, Patel VD, Chandwani HS. J Manag Care Spec Pharm; 2016 Jul; 22(7):808-817a. PubMed ID: 27348282 [Abstract] [Full Text] [Related]
26. The Association Between Adherence to Insulin Therapy and Health Care Costs for Adults with Type 2 Diabetes: Evidence from a U.S. Retrospective Claims Database. Eby EL, Bajpai S, Faries DE, Haynes VS, Lage MJ. J Manag Care Spec Pharm; 2020 Sep; 26(9):1081-1089. PubMed ID: 32857656 [Abstract] [Full Text] [Related]
27. Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis. Mitra D, Hodgkins P, Yen L, Davis KL, Cohen RD. BMC Gastroenterol; 2012 Sep 24; 12():132. PubMed ID: 23006789 [Abstract] [Full Text] [Related]
28. Evaluating the Effect of Treatment Persistence on the Economic Burden of Moderate to Severe Psoriasis and/or Psoriatic Arthritis Patients in the U.S. Department of Defense Population. Lee S, Xie L, Wang Y, Vaidya N, Baser O. J Manag Care Spec Pharm; 2018 Jul 24; 24(7):654-663. PubMed ID: 29952710 [Abstract] [Full Text] [Related]
29. Healthcare resource utilization and costs 2 years pre- and post-lumbar spine surgery for stenosis: a national claims cohort study of 22,182 cases. Koltsov JCB, Sambare TD, Alamin TF, Wood KB, Cheng I, Hu SS. Spine J; 2022 Jun 24; 22(6):965-974. PubMed ID: 35123048 [Abstract] [Full Text] [Related]
32. Treatment patterns, health care resource utilization, and costs associated with use of atypical antipsychotics as first vs subsequent adjunctive treatment in major depressive disorder. Jain R, Laliberté F, Germain G, Mahendran M, Higa S, Harrington A, Parikh M. J Manag Care Spec Pharm; 2023 Aug 24; 29(8):896-906. PubMed ID: 37523314 [Abstract] [Full Text] [Related]
34. Incremental burden of relapse in patients with major depressive disorder: a real-world, retrospective cohort study using claims data. Touya M, Lawrence DF, Kangethe A, Chrones L, Evangelatos T, Polson M. BMC Psychiatry; 2022 Mar 01; 22(1):152. PubMed ID: 35232411 [Abstract] [Full Text] [Related]
35. Real-World Health Plan Data Analysis: Key Trends in Medication Adherence and Overall Costs in Patients with HIV. Kangethe A, Polson M, Lord TC, Evangelatos T, Oglesby A. J Manag Care Spec Pharm; 2019 Jan 01; 25(1):88-93. PubMed ID: 30589631 [Abstract] [Full Text] [Related]
36. Characterizing Health Care Utilization, Direct Costs, and Comorbidities Associated with Interstitial Cystitis: A Retrospective Claims Analysis. Tung A, Hepp Z, Bansal A, Devine EB. J Manag Care Spec Pharm; 2017 Apr 01; 23(4):474-482. PubMed ID: 28345436 [Abstract] [Full Text] [Related]
37. Health Care Resource Utilization and Costs for Patients with Tardive Dyskinesia. Carroll B, Irwin DE. J Manag Care Spec Pharm; 2019 Jul 01; 25(7):810-816. PubMed ID: 31232207 [Abstract] [Full Text] [Related]
38. Patterns of Adherence to Oral Atypical Antipsychotics Among Patients Diagnosed with Schizophrenia. MacEwan JP, Forma FM, Shafrin J, Hatch A, Lakdawalla DN, Lindenmayer JP. J Manag Care Spec Pharm; 2016 Nov 01; 22(11):1349-1361. PubMed ID: 27783548 [Abstract] [Full Text] [Related]
39. Incremental Health Care Burden of Treatment-Resistant Depression Among Commercial, Medicaid, and Medicare Payers. Shrestha A, Roach M, Joshi K, Sheehan JJ, Goutam P, Everson K, Heerlein K, Jena AB. Psychiatr Serv; 2020 Jun 01; 71(6):593-601. PubMed ID: 32237982 [Abstract] [Full Text] [Related]
40. Economic Burden of Illness in Adult Patients with Nocturia. Dmochowski R, Brucker BM, Cole E, Kawahara S, Pulicharam R, Burk C, Tung A, Hale D. J Manag Care Spec Pharm; 2019 May 01; 25(5):593-604. PubMed ID: 30675816 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]